Zobrazeno 1 - 10
of 279
pro vyhledávání: '"Neuroprotective therapy"'
Publikováno v:
Exploration of Neuroprotective Therapy, Vol 4, Iss 1, Pp 55-71 (2024)
Acute ischemic stroke (AIS) is the leading cause of disability worldwide, and recanalization therapy is significant in the hyperacute phase of AIS. However, reperfusion injury and hemorrhagic transformation after recanalization predict poor prognosis
Externí odkaz:
https://doaj.org/article/71e885b7afae4e8189080cd6b0e7a03e
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
Amyotrophic lateral sclerosis (ALS) is a debilitating motor neurological disorder for which there is still no cure. The disease seriously jeopardizes the health and lifespan of adult populations. The authors extensively retrieved the current literatu
Externí odkaz:
https://doaj.org/article/237ca5194a7e446789654d7f10ba0f1d
Autor:
L. A. Shchepankevich, I. A. Gribacheva, T. F. Popova, E. V. Taneeva, K. V. Roerich, E. V. Petrova, M. S. Shchepankevich
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 15, Iss 4, Pp 74-79 (2023)
Cardiovascular factors significantly increase the risk of vascular cognitive impairment (VCI). Currently, there are no specific treatments for VCI. A promising therapeutic strategy is the administration of citicoline, which has a neuroprotective effe
Externí odkaz:
https://doaj.org/article/c96b34e68eb64c6587b1837a089adf50
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 15, Iss 2, Pp 106-113 (2023)
Vascular brain diseases are one of the leading causes of death and disability in developed countries. Along with acute disturbance of cerebral circulation, chronic cerebrovascular diseases, which manifest as vascular cognitive impairment (VCI), are o
Externí odkaz:
https://doaj.org/article/b784481761e843219c3d6e48808af49d
Autor:
З. Назирова, Д. Туракулова
Publikováno v:
Неонатологія, хірургія та перинатальна медицина, Vol 13, Iss 4(50) (2023)
Normalization of intraocular pressure is an indispensable condition, but it does not guarantee stabilization of the glaucomatous process. Neuroprotective therapy aimed at maintaining the active function of axons of ganglion cells is of great importan
Externí odkaz:
https://doaj.org/article/2a1e8be41fc24c0bb092ea0c8a0993b8
Publikováno v:
Вісник проблем біології і медицини, Iss 1, Pp 164-168 (2022)
The purpose of this study was to develop directions for possible correction of changes in cognitive function in patients with a surgical profile after general anesthesia in the early postoperative period against the background of neuroprotective ther
Externí odkaz:
https://doaj.org/article/e371167197e94084b284ea7dd1451d4c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Nature and Science of Sleep, Vol Volume 14, Pp 407-418 (2022)
Si-Yi Gong,1,* Yun Shen,1,* Han-Ying Gu,1 Sheng Zhuang,1 Xiang Fu,1,2 Qiao-Jun Wang,1 Cheng-Jie Mao,1 Hua Hu,1 Yong-Ping Dai,1 Chun-Feng Liu1– 3 1Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affil
Externí odkaz:
https://doaj.org/article/281ea6dea0fb42ed8d2dd4bfa3579222
Publikováno v:
Медицинский совет, Vol 0, Iss 2, Pp 135-145 (2022)
Introduction. In the Russian Federation, neuroprotective agents are widely used in the treatment of patients with ischemic stroke. There are accumulated data on the efficacy and safety of the neuroprotective agent Cellex® in ischemic stroke. The use
Externí odkaz:
https://doaj.org/article/40cae3d7c6e542f9a5498caacbd13b51
Publikováno v:
Сучасні медичні технології, Iss 3(50), Pp 22-30 (2021)
Parkinson's disease is a progressive disease with moderate age of the beginning of 55 years. Over time, symptoms worsen, and although levodopa has significantly improved the quality of life of patients with PD, statistics show that these patients con
Externí odkaz:
https://doaj.org/article/46c0b53d5ed94b7e98c734cb895568ef